Physician profile
Eric L Cole
NPI 1013968478
$10,571.42
in general payments reported to CMS, 2019-2025
62 companies · $830 in 2025
The $830 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,802 · 2020: $608 · 2021: $1,505 · 2022: $1,491 · 2023: $1,642 · 2024: $2,693 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,091 · Education: $75.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,090.66 |
| Education | $75.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,704.93 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,222.18 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $512.19 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $511.36 | 2019-2024 | Xifaxan |
| Amgen INC. | $507.41 | 2019-2025 | Evenity, Otezla, Repatha |
| Pfizer INC. | $460.37 | 2019-2025 | |
| Glaxosmithkline, LLC. | $443.04 | 2019-2024 | Shingrix |
| Novo Nordisk INC | $389.91 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amarin Pharma, INC. | $355.14 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $321.39 | 2020-2025 | |
| Abbott Laboratories | $308.04 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $223.61 | 2022-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Sanofi-Aventis U.S. LLC | $221.15 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $209.54 | 2019-2023 | Xyosted, Qelbree |
| Esperion Therapeutics, INC. | $205.68 | 2020-2025 | Nexletol |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.78 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $179.89 | 2019-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $178.95 | 2022-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $167.28 | 2019-2024 | Verquvo, Gardasil, Vaxelis |
| Janssen Pharmaceuticals, INC | $166.24 | 2019-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $149.60 | 2022-2025 | |
| Boston Scientific Corporation | $133.01 | 2024 | Wavewriter Alpha Prime 16 |
| Phathom Pharmaceuticals, INC. | $131.38 | 2024-2025 | Voquezna |
| Inari Medical, INC. | $127.17 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $112.57 | 2020-2023 | Trintellix |
| Gilead Sciences, INC. | $110.68 | 2019-2022 | |
| Abiomed | $97.24 | 2024-2025 | Impella |
| Kowa Pharmaceuticals America, INC. | $92.24 | 2022-2023 | Livalo, Seglentis |
| Shionogi INC | $84.55 | 2021-2022 | |
| Baxter Healthcare | $84.29 | 2022 | |
| Incyte Corporation | $75.06 | 2023 | Opzelura |
| Biohaven Pharmaceuticals, INC. | $70.13 | 2021 | |
| Eisai INC. | $63.69 | 2021-2025 | |
| Corium, LLC | $57.85 | 2022-2024 | Azstarys |
| Sumitomo Pharma America, INC. | $57.41 | 2024 | Gemtesa |
| Biohaven Pharmaceutical Holding Company LTD. | $50.66 | 2022 | |
| Recor Medical INC | $50.32 | 2024 | Paradise Renal Denervation System |
| Antares Pharma, INC. | $46.80 | 2023-2024 | Xyosted, Nocdurna, Tlando |
| Ultragenyx Pharmaceutical INC. | $44.79 | 2019-2021 | |
| Corcept Therapeutics | $43.57 | 2024-2025 | Korlym |
| Halozyme INC | $38.39 | 2023 | |
| Acadia Pharmaceuticals INC | $29.33 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $28.30 | 2023-2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $28.23 | 2023-2024 | Quviviq |
| Edwards Lifesciences Corporation | $27.13 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pharmacosmos Therapeutics INC. | $25.85 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.85 | 2021 | |
| Tandem Diabetes Care, INC. | $17.33 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $17.25 | 2024 | Crysvita |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.72 | 2024 | Caplyta |
| Melinta Therapeutics, LLC | $16.39 | 2022 | |
| Upsher-Smith Laboratories LLC | $16.32 | 2022 | |
| Axsome Therapeutics, INC. | $15.67 | 2025 | Symbravo |
| Agios Pharmaceuticals, INC. | $15.10 | 2023 | Pyrukynd |
| Medtronic, INC. | $14.67 | 2022 | |
| Allergan, INC. | $14.45 | 2019 | |
| Seqirus USA INC | $14.39 | 2022 | |
| Cranial Technologies, INC | $13.77 | 2023 | Doc Band |
| Intuity Medical INC | $13.56 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ironwood Pharmaceuticals, INC | $12.88 | 2019 | |
| Mannkind Corporation | $12.14 | 2019 | |
| Vyera Pharmaceuticals, LLC | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.